Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedure

NCT: NCT02628509 · COMPLETED

NCT IDNCT02628509
StatusCOMPLETED
Start Date2012-08-01
Completion2018-01-31

Brief Summary

The WITAVI study was designed to explore the kinetic and associated outcome of Von Willebrand Factor-multimerizaton defects associated with devices in cardiovascular diseases.

Frequently Asked Questions

What is Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedure?

Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedure is a clinical trial registered under NCT02628509. Current status: COMPLETED.

What is the status of NCT02628509?

The current status of NCT02628509 (Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedure) is: COMPLETED.

When did Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedure start?

Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedure started on 2012-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑